MedPath

Aldumastat

Generic Name
Aldumastat

A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis

Phase 2
Completed
Conditions
Osteoarthritis
Interventions
Drug: Placebo
First Posted Date
2018-07-23
Last Posted Date
2021-07-28
Lead Sponsor
Galapagos NV
Target Recruit Count
932
Registration Number
NCT03595618
Locations
🇺🇸

The Helm Center for Pain Management, Laguna Hills, California, United States

🇺🇸

Pioneer Research Solutions Inc., Houston, Texas, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

and more 41 locations

Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2017-05-08
Last Posted Date
2017-06-20
Lead Sponsor
Galapagos NV
Target Recruit Count
12
Registration Number
NCT03143725
Locations
🇧🇪

SGS Belgium Life Sciences, Antwerp, Belgium

© Copyright 2025. All Rights Reserved by MedPath